Overview
PureTech is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others.
For Investor Relations inquiries, please contact PureTech's Investor Relations team at: ir@puretechhealth.com.
View our corporate deck.
Share Price
Price
Change
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Half Year Report 2020
Corporate Presentation